News | Peripheral Artery Disease (PAD) | December 29, 2017

Oceanus 14 Pro PTA Balloon Catheter Receives CE Mark Approval

Device approved to dilate stenoses in femoral, popliteal and infrapopliteal arteries

December 29, 2017 — iVascular announced the release of the new Oceanus 14 Pro percutaneous transluminal angioplasty (PTA) balloon catheter following CE Mark approval. The device was approved to dilate stenoses in femoral, popliteal and infrapopliteal arteries, and to treat obstructive lesions in arteriovenous dialysis fistulae.

Oceanus 14 Pro features what the company calls an exceptional crossing profile and size range, including ultra-small diameters (1.25mm and 1.5mm) and lengths (10mm and 15mm). It is the only PTA catheter that adapts its number and type of radiopaque markers for enhanced visibility, flexibility and trackability:

  • One tungsten radiopaque marker for the smallest and shortest balloons;
  • Two tungsten radiopaque markers for smaller diameters and lengths over 20mm; and
  • Two metallic radiopaque markers for other references.

For more information: www.ivascular.global


Related Content

News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
News | Peripheral Artery Disease (PAD)

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

Home November 10, 2023
Home
News | Peripheral Artery Disease (PAD)

October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
News | Peripheral Artery Disease (PAD)

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
News | Peripheral Artery Disease (PAD)

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

Home July 11, 2023
Home
News | Peripheral Artery Disease (PAD)

June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of ...

Home June 21, 2023
Home
News | Peripheral Artery Disease (PAD)

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

Home June 16, 2023
Home
News | Peripheral Artery Disease (PAD)

June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...

Home June 15, 2023
Home
News | Peripheral Artery Disease (PAD)

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

Home March 08, 2023
Home
Subscribe Now